H.I.G. Capital News / 2022
-
November 22, 2022 - BIOVECTRA Named One of Canada’s Top Employers Again in 2023
Charlottetown, P.E.I. – November 22, 2022 – BIOVECTRA was selected as one of Canada’s Top 100 Employers for a second consecutive year and is considered amongst the country’s leading workplaces. BIOVECTRA is a fast growing, forward-thinking contract development, and manufacturing…
-
PALO ALTO, CALIFORNIA – October 4, 2022 – Endpoint Health, Inc., a Precision-FirstTM therapeutics company, today unveiled its newest precision immunology program targeting inflammation mediated by tissue factor (TF)- dependent intracellular signaling. The company will leverage its…
-
September 15, 2022 - Zerigo Health Announces Release of Eczema Solution
SAN DIEGO, CALIFORNIA – September 15, 2022 – Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go, today announced the launch of a new software release which includes integration of the American Academy…
-
BLOOMFIELD, CONNECTICUT – September 15, 2022 – Evernorth, the health services business of Cigna Corporation ( NYSE: CI), has expanded its Digital Health Formulary to include five new app-based programs to help people better manage their sleep issues, anxiety, alcohol and opioid…
-
SALT LAKE CITY, UTAH – September 8, 2022 – Artemis Health, a best-in-class benefits analytics platform announced a partnership with Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go. This partnership…
-
June 29, 2022 - Leiters Joins the End Drug Shortages Alliance
DENVER – June 29, 2022 – Leiters, a trusted FDA-registered 503B outsourcing provider of compounded sterile preparations and pharmacy services, announced today it has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The End Drug Shortages…
-
DENVER – June 9, 2022 – Today Leiters has announced that Memorial Hermann Health System – a non-profit, community-focused, award-winning health system committed to creating healthier Houston communities – has joined the company’s growing list of strategic health system investor…
-
BRIDGEWATER, NJ – April 28, 2022 – Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings, and announced today that…
-
April 15, 2022 - Click Therapeutics Closes $15 Million Debt Financing from Silicon Valley Bank
NEW YORK – April 15, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has secured a $15 million term loan from Silicon Valley Bank. Proceeds from the financing were used in part to retire…
-
PARIS & BOSTON – March 8, 2022 – On Target Laboratories, Inc. (‘On Target’) a privately-held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery and Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY)…
-
March 2, 2022 - H.I.G. Capital Expands BioHealth Team with Addition of Gwen Watanabe
STAMFORD – March 2, 2022 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $47 billion of equity capital under management, is pleased to announce that Gwen Watanabe has joined the firm’s dedicated life-science investment affiliate, H.I.G.…
-
DENVER – February 8, 2022 – Leiters, a trusted FDA-registered 503B outsourcing provider of hospital and ophthalmology compounded sterile preparations announced today that it has completed the purchase of a new manufacturing facility in Buena, New Jersey. The 110,000 square foot…
-
CHICAGO – January 18, 2022 – Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced its newest executive leadership addition in support of the accelerating growth of the company’s revolutionary AR-driven xvision system®. The company announced the…